A carregar...
Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept
In the last few years, monoclonal antibodies have revolutionized the treatment of retinal neovascular diseases. More recently, a different class of drugs, fusion proteins, has provided an alternative treatment strategy with pharmacological differences. In addition to commercially available afliberce...
Na minha lista:
| Publicado no: | Int J Retina Vitreous |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5088480/ https://ncbi.nlm.nih.gov/pubmed/27847621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-016-0026-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|